Sort
39,280 grants matching “leukemia”
Mouse Models of Myeloid Leukemia
$850,000University Of California San Francisco · U01 · FY2004 · CA
Center for Integrative Research on Childhood Leukemia and the Environment
$850,000Catherine Metayer · University Of California Berkeley · P50 · FY2017 · ES
Nongenotoxic conditioning for gene therapy and allogeneic transplantation in Fanconi anemia
$849,490Hans-Peter Kiem · Fred Hutchinson Cancer Research Center · R01 · FY2020 · HL
Molecular pathways and targeted therapies in human leukemia
$849,333Adolfo A. Ferrando · Columbia University Health Sciences · R35 · FY2017 · CA
Beta3 Integrins - Translation of Molecular Structure to Improved Therapeutics
$848,310Barry Coller · Rockefeller University · R01 · FY2017 · HL
ECOG Specimen Banking
$848,204Robert L Comis · Frontier Sci & Technology Rsch Fdn, Inc · U24 · FY2014 · CA
ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)
$848,075Ross L Levine · Sloan-Kettering Inst Can Research · UG1 · FY2025 · CA
ECOG-ACRIN Integrated Leukemia Translational Science Center (LTSC)
$848,075Ross L Levine · Sloan-Kettering Inst Can Research · UG1 · FY2024 · CA
Vaccines and Therapeutics for Anthrax
$847,612Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
NON-ACUTE RETROVIRUSES AND DETERMINANTS OF ONCOGENICITY
$847,523University Of Pennsylvania · P01 · FY2001 · CA
Multiscale Modeling of Myelodysplastic Syndromes
$847,513Seth Joel Corey · Cleveland Clinic Lerner Com-Cwru · R01 · FY2019 · HL
Follow-Up Studies of a Genome-Wide Association Analysis in Pima Indians
$847,201Leslie J Baier · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2022 · DK
Optimizing the graft versus leukemia effect for pediatric ALL
$846,887Terry Fry · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Defining the Mechanisms of Immune Escape After Adoptive T cell Therapies
$846,699Geoffrey Roger Hill · Fred Hutchinson Cancer Center · P01 · FY2024 · CA
Early intervention with anti-proliferative therapy close to ART initiation to limit long-term SIV persistence
$846,498Joshua Tisdell Schiffer · Fred Hutchinson Cancer Center · R01 · FY2025 · AI
PEDIATRIC CHTN--AIDS CANCER RESEARCH
$846,226Research Inst Nationwide Children'S Hosp · U01 · FY2004 · CA
NHGRI/DIR Genomics Core
$846,147Settara Chandrasekharappa · National Human Genome Research Institute · ZIC · FY2019 · HG
FANCONI ANEMIA:GENOTYPE-PHENOTYPE CORRELATIONS
$846,147Settara Chandrasekharappa · National Human Genome Research Institute · ZIA · FY2019 · HG
Cancer and Leukemia Group B Human Specimen Repositories
$846,033Monica M Bertagnolli · Brigham And Women'S Hospital · U24 · FY2011 · CA
The IL-18-IFNγ axis predicts response to immunotherapy
$845,823Heather Leigh Herd Gustafson · Seattle Children'S Hospital · R37 · FY2023 · CA
Core C - Sequencing and Analysis.
$845,750Christopher A Miller · Washington University · P01 · FY2022 · CA
A Single-Cell Device to Detect Pathogenic Cell Populations in Bone Marrow Disease
$845,621Timothy S McConnell · Isoplexis, Inc. · R44 · FY2017 · EB
A Single-Cell Device to Detect Pathogenic Cell Populations in Bone Marrow Disease
$845,621Timothy S McConnell · Isoplexis, Inc. · R44 · FY2018 · EB
Defining the Mechanisms of Immune Escape After Adoptive T cell Therapies
$845,088Geoffrey Roger Hill · Fred Hutchinson Cancer Center · P01 · FY2025 · CA
Characterization of brain dysfunction during development in survivors of childhood acute lymphoblastic leukemia
$844,664Elyse S Sussman · Albert Einstein College Of Medicine · R01 · FY2024 · CA